| 14th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Nov 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Nov 2025 3:30 pm |
RNS |
Block listing Interim Review |
| 12th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Nov 2025 3:00 pm |
RNS |
GSK publishes provisional dividend dates |
| 10th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 7th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 6th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 5th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 3rd Nov 2025 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Nov 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 31st Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Oct 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 30th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 29th Oct 2025 7:05 am |
RNS |
Transaction in Own Shares |
| 29th Oct 2025 7:00 am |
RNS |
3rd Quarter Results |
| 28th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th Oct 2025 7:00 am |
RNS |
GSK ADC gets orphan drug designation in the EU |
| 27th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Oct 2025 7:00 am |
RNS |
Blenrep approved by US FDA in multiple myeloma |
| 24th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Oct 2025 7:05 am |
RNS |
Positive data for low carbon version Ventolin MDI |
| 22nd Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Oct 2025 7:00 am |
RNS |
Latozinemab data read out |
| 21st Oct 2025 7:05 am |
RNS |
Positive CHMP Opinion for GSK on Shingrix PFS |
| 21st Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 21st Oct 2025 7:00 am |
RNS |
GSK share positive Ph3 data on tebipenem HBr |
| 20th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Oct 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Oct 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Oct 2025 7:00 am |
RNS |
GSK receives expanded Shingrix approval in China |
| 14th Oct 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Oct 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
